2 minute read
A vial labelled with the AstraZeneca coronavirus disease (COVID-19) vaccine is seen in this illustration picture taken March 19, 2021. REUTERS/Dado Ruvic/Illustration
Malaysian health authorities said on Friday conditional approval had been granted for AstraZeneca s COVID-19 vaccine manufactured by Siam Bioscience Co in Thailand.
Health Ministry director-general, Noor Hisham Abdullah, said in a statement the vaccine supply received from Thailand is expected to speed up implementation of Malaysia s national vaccination programme.
The government had previously put the AstraZeneca vaccine in a parallel optional programme after reports of possible links to very rare blood clots. read more
But the vaccine was brought back into the national immunisation programme last week after hundreds of thousands of people scrambled to get the shot.
Moderna package likely below B3,000
Moderna package likely below B3,000
THAILAND: The price for a package of two shots of Moderna COVID-19 vaccine offered by private hospitals will be no more than B3,000, hospital executives say.
Sunday 9 May 2021, 09:06AM
Moderna is likely to be the first brand to be ordered by the Government Pharmaceutical Organization on behalf of private hospitals. Photo: AFP.
The Private Hospital Association announced the plan after a meeting on Thursday (May 6) to discuss a common approach to offering alternative vaccines. Moderna is likely to be the first brand to be ordered by the Government Pharmaceutical Organization (GPO) on their behalf.
Photo used for illustration purposes only
PUTRAJAYA – Malaysia will continuously evaluate all types of COVID-19 vaccines being developed including the nasal spray type for the immunisation programme, said Coordinating Minister for the National COVID-19 Immunisation Programme, Khairy Jamaluddin.
However, he said Malaysia currently had made adequate COVID-19 vaccine bookings for the use of the population in the country.
Advertisement
“Malaysia has ordered enough vaccine to cover 110 per cent of our population.
“If we later decide that the nature of this pandemic has become endemic, that it is here to stay, then obviously there will be longer term procurement strategy for vaccines,” he said.
AstraZeneca, manufacturers committed to safety and quality of vaccine
A
-
Biopharmaceutical company AstraZeneca and its global manufacturing partners including Siam Bioscience Co. Ltd (Siam Bioscience) are committed to maintaining the highest safety and quality standards of their Covid-19 vaccine.
Country president AstraZeneca (Thailand) Ltd James Teague said each batch of the vaccine undergoes more than 60 different quality control tests during its journey from manufacture to vaccination.
“The process takes time, and it is designed to assure.
All Access Plan
Siam Bioscience confident of delivering vaccine jabs on time
11
published : 18 Apr 2021 at 05:00
11
Siam Bioscience Co, the local biotechnology firm contracted to manufacture the AstraZeneca Covid-19 vaccine in Thailand, said it is confident that it will be able to deliver the vaccines on time once they have passed the required checks.
The company is in the process of sending samples of the vaccines it produced to several laboratories in Europe and the United States for quality inspection.
Once the samples are approved by the labs, they will be sent to AstraZeneca, which will then register the vaccine with the Thai Food and Drug Administration, so it can be mass-produced and used domestically, the company said.